Las Vegas, NV -- (SBWIRE) -- 12/10/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.EquityObserver.com issues a special report on the following stocks: Allied Nevada Gold Corp.(NYSEMKT:ANV), Rambus Inc (NASDAQ:RMBS), BG Medicine, Inc.(NASDAQ:BGMD), AngloGold Ashanti Limited (ADR)(NYSE:AU)
Allied Nevada Gold Corp.(NYSEMKT:ANV) increased 12.15% at the price of $3.60 recently on a traded volume of 4.44 million shares, in comparison to 3.65 million shares of average trading volume. So far this year, the stock is down over -87.99%.
The company has a total market capitalization of $376.28 million and its total outstanding shares are 103.94 million. Allied Nevada Gold Corp. (Allied Nevada) is a gold and silver producer focused on mining, development, and exploration of properties in the state of Nevada. The Company’s operating mine, the Hycroft Mine, is an open-pit gold and silver heap leach operation located 54 miles west of Winnemucca, Nevada
For How Long ANV will Fight for Profitability? Read This Trend Analysis report
Rambus Inc (NASDAQ:RMBS) soared 16.30% at the trading price of $9.99 on a traded volume of 5.24 million shares till now, whereas its average trading volume is 620,066.00 shares. In the last three months, the stock is up 9.76%. The Intra-day range for the stock is $9.25 and $10.57. Rambus Inc. (Rambus) is a technology solutions company. The Company invents, develops, offers and licenses solutions that challenge and enable its customers to create the future. It also develops products and services in security, advanced LED lighting and displays, and immersive mobile media. The Company has four business units: Memory and Interfaces Division,.
For How Long RMBS Gloss will Attract Investors? Find out via this report
BG Medicine, Inc.(NASDAQ:BGMD) jumped up 89.66% at the $1.09 recently. So far in three months, the stock is up 19.98%. The 52-week range for the stock is $0.55 and $4.48. Its introductory price for the day was $0.65, with the overall traded volume of 6.84 million shares. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque.
Will BGMD Continue To Move Higher? Find Out Here
AngloGold Ashanti Limited (ADR)(NYSE:AU), after opening its shares at the price of $12.65, jumped up 9.39% , its recent trading price was $13.28 for the day. The stock moved on a traded volume of 2.57 million shares, in comparison 2.99 million shares of average trading volume.
The 52-week range for the stock is $11.62 and $31.88. Its introductory price for the day was $12.65. AngloGold Ashanti Limited (AngloGold Ashanti) is a gold mining company with a portfolio of assets and differing orebody types in key gold producing regions. The Company also produces silver, uranium oxide and sulfuric acid as by-products. AngloGold Ashanti has 20 operations in four regions consisting of open-pit and underground mines and surface metallurgical plants in 10 countries on four continents.
Why Should Investors Buy AU After The Recent Gain? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)